The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Propofol: The Challenges of Formulation
Abstract
Propofol is a potent lipophilic anesthetic that was initially formulated in Cremophor El for human use. Because of the occurrence of Cremophor EL anaphylaxis and improvements in the quality of lipid emulsions, it was ultimately brought to market as 1% propofol formulated in 10% soybean oil emulsion. Emulsions represent complex formulation compositions whose suitability for intravenous administration is dependent on a number of factors. Despite the success of propofol emulsions, drawbacks to such formulations include inherent emulsion instability, injection pain, a need for antimicrobial agents to prevent sepsis, and a concern of hyperlipidemia-related side effects. Efforts to overcome such drawbacks have involved the development of propofol emulsions with altered propofol and lipid contents, the addition of different excipients to emulsions for antimicrobial activity, and study of nonemulsion formulations including propofol-cyclodextrin and propofol-polymeric micelle formulations. In addition, a number of propofol prodrugs have been made and evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rates
Schywalsky, M., Ihmsen, H., Tzabazis, A., Fechner, J., Burak, E. S., Vornov, J. J., & Schwilden, H. (2005) · European Journal of Anaesthesiology · doi:10.1017/s0265021503000322 · Cited by 41
RetractedCyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Schnider, T. W., Minto, C. F., Gambus, P. L., Andresen, C., Goodale, D. B., Shafer, S. L., & Youngs, E. J. (1998) · Anesthesiology · doi:10.1097/00000542-199805000-00006 · Cited by 1,162
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Parke, T. J., Stevens, J. E., Rice, A. S., Greenaway, C. L., Bray, R. J., Smith, P. J., Waldmann, C. S., & Verghese, C. (1992) · BMJ · doi:10.1136/bmj.305.6854.613 · Cited by 579
Propofol infusion syndrome in children
Bray (1998) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.1998.00282.x · Cited by 533
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · cited 1×
“Such polymeric micelles are small with particle diameters ranging in size from 20 to 80 nm, which, as noted for such small particles in solution, gives them a clear visual appearance.(154) Rather than having a well-defined interface between the lipophilic component and water as in phospholipid emulsions, micelles have…”
BackgroundReview of the toxicologic properties of medium-chain triglycerides
Traul, K. A., Driedger, A., Ingle, D. L., & Nakhasi, D. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00106-4 · Cited by 429
Cited by
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809
Chiappetta, D. A., & Sosnik, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.022 · Cited by 567
Anaphylaxis—a practice parameter update 2015
Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474
Prevention of pain on injection of propofol: systematic review and meta-analysis
Jalota, L., Kalira, V., George, E., Shi, Y.-Y., Hornuss, C., Radke, O., Pace, N. L., Apfel, C. C., & Core, O. B. O. T. P. C. R. (2011) · BMJ · doi:10.1136/bmj.d1110 · Cited by 354
Metadata
- Authors
- Baker, M. T., Naguib, M., & Warltier, D. C.
- Venue
- Anesthesiology
- Published
- 2005-10-01
- Volume
- 103
- Issue
- 4
- Pages
- 860-876
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2089670500
- Cited by
- 305
- References
- 40
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Propofol: The Challenges of Formulation. https://app.cochat.ai/papers/10.1097/00000542-200510000-00026
- The paper
- Baker, M. T., Naguib, M., & Warltier, D. C. (2005). Propofol: The Challenges of Formulation. Anesthesiology. https://doi.org/10.1097/00000542-200510000-00026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.